Engineering out the risk for infection with urinary catheters

D G Maki, P A Tambyah, D G Maki, P A Tambyah

Abstract

Catheter-associated urinary tract infection (CAUTI) is the most common nosocomial infection. Each year, more than 1 million patients in U.S. acute-care hospitals and extended-care facilities acquire such an infection; the risk with short-term catheterization is 5% per day. CAUTI is the second most common cause of nosocomial bloodstream infection, and studies suggest that patients with CAUTI have an increased institutional death rate, unrelated to the development of urosepsis. Novel urinary catheters impregnated with nitrofurazone or minocycline and rifampin or coated with a silver alloy-hydrogel exhibit antiinfective surface activity that significantly reduces the risk of CAUTI for short-term catheterizations not exceeding 2-3 weeks.

References

    1. Arch Intern Med. 2000 Mar 13;160(5):678-82
    1. Mayo Clin Proc. 1999 Feb;74(2):131-6
    1. JAMA. 1972 Sep 11;221(11):1270-1
    1. N Engl J Med. 1978 Sep 14;299(11):570-3
    1. N Engl J Med. 1980 Aug 7;303(6):316-8
    1. Am J Med. 1981 Mar;70(3):719-32
    1. N Engl J Med. 1982 Sep 9;307(11):637-42
    1. Urology. 1999 Dec;54(6):976-81
    1. Acta Chir Scand. 1982;148(4):323-7
    1. Infect Control. 1982 Nov-Dec;3(6):466-70
    1. Lancet. 1983 Apr 23;1(8330):893-7
    1. J Infect Dis. 1983 Jul;148(1):57-62
    1. N Engl J Med. 1984 Aug 30;311(9):560-4
    1. J Urol. 1984 Sep;132(3):494-8
    1. JAMA. 1984 Oct 19;252(15):2028-30
    1. Lancet. 1986 Nov 1;2(8514):1031
    1. Am J Epidemiol. 1986 Dec;124(6):977-85
    1. Arch Intern Med. 1989 Jan;149(1):30-5
    1. J Urol. 1989 Mar;141(3):535-7
    1. Br J Urol. 1990 Apr;65(4):379-81
    1. Eur Urol. 1990;17(3):236-40
    1. J Infect Dis. 1990 Nov;162(5):1145-50
    1. Med Clin North Am. 1991 Mar;75(2):495-513
    1. Am J Infect Control. 1991 Jun;19(3):136-42
    1. Am J Med. 1991 Sep 16;91(3B):65S-71S
    1. Am J Epidemiol. 1992 Feb 1;135(3):291-301
    1. Arch Intern Med. 1992 Apr;152(4):807-12
    1. Lancet. 1992 Apr 18;339(8799):946-51
    1. J Antimicrob Chemother. 1992 Apr;29 Suppl A:19-24
    1. Eur Urol. 1993;24(1):27-30
    1. J Antimicrob Chemother. 1994 May;33 Suppl A:31-41
    1. Am J Med. 1995 Apr;98(4):349-56
    1. Infect Control Hosp Epidemiol. 1996 Apr;17(4):212-4
    1. Ann Intern Med. 1997 Aug 15;127(4):257-66
    1. Infect Dis Clin North Am. 1997 Sep;11(3):609-22
    1. Am J Med. 1998 Sep;105(3):236-41
    1. Transplant Proc. 1998 Dec;30(8):4314-6
    1. N Engl J Med. 1966 May 26;274(21):1155-61

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever